Cargando…
Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast
The increased spread of drug-resistant malaria highlights the need for alternative drugs for treatment and chemoprophylaxis. The combination of atovaquone‐proguanil (Malarone®) has shown high efficacy against Plasmodium falciparum with only mild side-effects. Treatment failures have been attributed...
Autores principales: | Wurtz, Nathalie, Pascual, Aurélie, Marin-Jauffre, Adeline, Bouchiba, Housem, Benoit, Nicolas, Desbordes, Marc, Martelloni, Maryse, de Santi, Vincent Pommier, Richa, Georges, Taudon, Nicolas, Pradines, Bruno, Briolant, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447648/ https://www.ncbi.nlm.nih.gov/pubmed/22551095 http://dx.doi.org/10.1186/1475-2875-11-146 |
Ejemplares similares
-
Plasmodium falciparum Malaria and Atovaquone-Proguanil Treatment Failure
por: Durand, Rémy, et al.
Publicado: (2008) -
Atovaquone/proguanil‐induced autoimmune‐like hepatitis
por: Terziroli Beretta‐Piccoli, Benedetta, et al.
Publicado: (2017) -
Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria
por: Blanshard, Andrew, et al.
Publicado: (2021) -
Tolerability of Atovaquone—Proguanil Application in Common Buzzard Nestlings
por: Wiegmann, Anja, et al.
Publicado: (2022) -
A survey on outcomes of accidental atovaquone–proguanil exposure in pregnancy
por: Tan, Kathrine R., et al.
Publicado: (2018)